The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
Enzymes are the molecular machines that power life; they build and break down molecules, copy DNA, digest food, and drive ...
Scientists are testing the ancient herb borage to see which healing claims hold up and where modern evidence still falls ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...
FREDERICK, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...
The Cambridge, Massachusetts-based company – known as FogPharma until a rebrand in 2024 – needs cash for pivotal trials of ...
Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...
A new Yale-led study published Thursday identified a new target for treating the most common form of cancer in children and ...
USU chemists’ CRISPR discovery could lead to single diagnostic test for viruses like COVID, flu, RSV
Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...
Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback